The formation of partnerships between pharmaceutical and biotechnology companies has been a critical factor in the international development of the biotechnology industry. Partnering enables access to both development expertise and capital. It also externally validates a company’s technology or products. A successful strategic corporate partnership takes advantage of strengths of each component at the appropriate time. Breslin offers corporate partnering services at any stage of product or company development. Breslin acts not only as an advisor. Breslin’s managing partners have the operational and financial expertise to actively manages individual corporate or business development projects on a contractual basis. Breslin’s European management team and global advisors have extensive industrial, financial and transaction expertise in the life sciences and technology industry. Through an impressive global network of Investment Bank, VC, Multi National Pharma, Biotech Medtech and IT companies, Breslin has proven success in managing over 30 partnering/M&A transactions.
Breslin offers a wide range of business development services such as co-development deals, joint ventures, licensing arrangements, mergers and acquisitions. Having completed over 30 successful partnering transactions, Breslin has extensive know how in deal sourcing, business development, structuring and execution of transactions. Breslin’s strong network of key international executives and access to major global industry players in Biotech, Pharma, Diagnostics and Devices is paramount to our success.
Within the life sciences market, the number of licensing deals per year is steadily increasing while the average value per deal is on an exponential rise. In-licensing is a way to avoid expensive and time-consuming research and development and out-licensing is a means to commercially export a technology in exchange for valuable resources. Breslin has extensive expertise managing licensing transactions focusing on small to medium sized deals between €5m-€50m. Breslin provides support and advice on confidentiality issues, indemnification, ownership and rights of IP, deal negotiation, obligations to the licensee and licensor, up front and milestone payments, termination and exit strategies.
Relationships may take many forms, including co-development agreements, mergers, acquisitions and licensing of technology or products. The bio-partnership or bio-alliance has become a very effective alternative to access critical funding for early stage development companies. Breslin are trusted partners for establishing strategic alliances between companies. Breslin has a strong network of industry leaders including large private equity houses, institutional investors as well as pharmaceutical and biotech companies. Breslin is able to provide clients valuable access to many leading companies for all aspects of corporate development needs.